Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:1082

Hyperlipidemia Global Clinical Trials Review, Q2, 2011

Hyperlipidemia Global Clinical Trials Review, Q2, 2011

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $1,000.00
Meta Description Hyperlipidemia Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, “Hyperlipidemia Global
Publisher GlobalData
Date of Report Jun 15, 2011
Quick Overview
Hyperlipidemia Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, “Hyperlipidemia Global Clinical Trials Review, Q2, 2011" provides data on the Hyperlipidemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperlipidemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyperlipidemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Hyperlipidemia 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Unaccomplished Trials of Hyperlipidemia 21
Subjects Recruited Over a Period of Time 23
Prominent Sponsors 24
Top Companies Participating in Hyperlipidemia Therapeutics Clinical Trials 26
Prominent Drug Comparison 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Pfizer Inc. 29
Clinical Trial Overview of Pfizer Inc. 29
Merck & Co., Inc. 32
Clinical Trial Overview of Merck & Co., Inc. 32
AstraZeneca PLC 33
Clinical Trial Overview of AstraZeneca PLC 33
Abbott Laboratories 34
Clinical Trial Overview of Abbott Laboratories 34
Solvay Pharmaceuticals, Inc. 35
Clinical Trial Overview of Solvay Pharmaceuticals, Inc. 35
Japan Tobacco Inc. 36
Clinical Trial Overview of Japan Tobacco Inc. 36
Kowa Research Institute, Inc. 37
Clinical Trial Overview of Kowa Research Institute, Inc. 37
Takeda Pharmaceutical Company Limited 38
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 38
Cadila Pharmaceuticals Ltd. 39
Clinical Trial Overview of Cadila Pharmaceuticals Ltd. 39
Daiichi Sankyo, Inc. 40
Clinical Trial Overview of Daiichi Sankyo, Inc. 40
Beijing Double-Crane Pharmaceutical Co., Ltd. 41
Clinical Trial Overview of Beijing Double-Crane Pharmaceutical Co., Ltd. 41
Harvard Pilgrim Health Care, Inc. 42
Clinical Trial Overview of Harvard Pilgrim Health Care, Inc. 42
Hanmi Pharmaceutical Co Ltd 43
Clinical Trial Overview of Hanmi Pharmaceutical Co Ltd 43
Samyang Corporation 44
Clinical Trial Overview of Samyang Corporation 44
Group Health Cooperative 45
Clinical Trial Overview of Group Health Cooperative 45
Kaiser Permanente 46
Clinical Trial Overview of Kaiser Permanente 46
Daiichi Sankyo Company, Ltd 47
Clinical Trial Overview of Daiichi Sankyo Company, Ltd 47
Amgen Inc. 48
Clinical Trial Overview of Amgen Inc. 48
Shionogi & Co., Ltd. 49
Clinical Trial Overview of Shionogi & Co., Ltd. 49
Covidien plc 50
Clinical Trial Overview of Covidien plc 50
Clinical Trial Overview of Top Universities / Institutes / Hospitals 51
University of Toronto 51
Clinical Trial Overview of University of Toronto 51
The National Institute of Diabetes and Digestive and Kidney Diseases 52
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 52
Stanford University 53
Clinical Trial Overview of Stanford University 53
Hiroshima University Hospital 54
Clinical Trial Overview of Hiroshima University Hospital 54
University of Manitoba 55
Clinical Trial Overview of University of Manitoba 55
Chestnut Hill Health System 56
Clinical Trial Overview of Chestnut Hill Health System 56
Niigata Rosai Hospital 57
Clinical Trial Overview of Niigata Rosai Hospital 57
University of California, San Francisco 58
Clinical Trial Overview of University of California, San Francisco 58
U.S. Department of Veterans Affairs 59
Clinical Trial Overview of U.S. Department of Veterans Affairs 59
University of Calgary 60
Clinical Trial Overview of University of Calgary 60
Vanderbilt University 61
Clinical Trial Overview of Vanderbilt University 61
Oregon Health and Science University 62
Clinical Trial Overview of Oregon Health and Science University 62
Tufts University 63
Clinical Trial Overview of Tufts University 63
University of Missouri 64
Clinical Trial Overview of University of Missouri 64
Saarland University Hospital 65
Clinical Trial Overview of Saarland University Hospital 65
Temple University 66
Clinical Trial Overview of Temple University 66
The National Institute of Allergy and Infectious Diseases 67
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 67
Nagoya University 68
Clinical Trial Overview of Nagoya University 68
The Federico II University 69
Clinical Trial Overview of The Federico II University 69
Walter Reed Army Medical Center 70
Clinical Trial Overview of Walter Reed Army Medical Center 70
Appendix 71
Abbreviations 71
Definitions 71
Research Methodology 72
Secondary Research 72
About GlobalData 72
Contact Us 72
Disclaimer 73
Source 73




...